Anita Krähenbühl-Melcher

Suggest Changes
Learn More
BACKGROUND Drug-drug interactions (DDIs) are a well known risk factor for adverse drug reactions. HMG-CoA reductase inhibitors ('statins') are a cornerstone in the treatment of dyslipidaemia and(More)
  • 1